6849
NIHON KOHDEN CORPORATION
日本光電工業株式会社Nihon Kohden Corporation engages in research and development, production, sales, and repair and maintenance of medical electronic equipment in Japan, North America, Latin America, Europe, Asia, and internationally. It offers physiological measuring equipment, such as electroencephalographs, evoked potential and electromyogram measuring systems, electrocardiographs, polygraphs for Cath lab, diagnostic information systems, recording paper, electrodes, and EP catheters. The company also provides patient monitors such as central monitors, bedside monitors, wireless monitors, remote access software and other equipment, clinical information systems, and electrodes and sensors. In addition, it offers Defibrillators, AEDs, ventilators, pacemakers, anesthesia machines, cochlear implants, automated chest compression devices, AED pads, batteries, and ablation catheters; hematology analyzers, clinical chemistry analyzers, ultrasound diagnostic equipment and others, consumables, including test reagents, and installation and maintenance services. Further, it is involved in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.
Price
¥1,447
Market Cap
¥236.0B
Ent. Value
¥225.3B
Net Cash
¥10.7B
Shares Out.
163.1M
P / E
16.2×
EV / EBIT
12.0×
P / Book
1.29×
P / NCAV
2.33×
Div. Yield
1.11%
Financials
| Metric |
FY 2025
TDnet |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|---|
| Net Sales | ¥235.1B | ¥225.4B | ¥222.0B | ¥206.6B | ¥205.1B |
| Cost of Sales | ¥113.4B | ¥108.3B | ¥110.6B | ¥100.7B | ¥96.0B |
| Gross Profit | ¥121.7B | ¥117.2B | ¥111.3B | ¥105.9B | ¥109.1B |
| SG&A | ¥103.0B | ¥96.4B | ¥91.8B | ¥84.8B | ¥78.1B |
| Operating Income | ¥18.7B | ¥20.7B | ¥19.6B | ¥21.1B | ¥31.0B |
| Non-Operating Income | ¥4.5B | ¥1.1B | ¥6.3B | ¥3.2B | ¥3.9B |
| Dividend Income | — | ¥144M | ¥130M | ¥119M | ¥107M |
| Interest Income | — | ¥428M | ¥289M | ¥194M | ¥132M |
| Non-Operating Expenses | — | ¥1.4B | ¥265M | ¥228M | ¥301M |
| Interest Expense | — | ¥144M | ¥24M | ¥10M | ¥11M |
| Ordinary Income | ¥22.5B | ¥20.4B | ¥25.6B | ¥24.1B | ¥34.6B |
| Pre-tax Income | ¥19.9B | ¥21.6B | ¥29.4B | ¥24.7B | ¥34.3B |
| Income Taxes | ¥5.4B | ¥7.5B | ¥12.3B | ¥7.6B | ¥10.8B |
| Current Tax | — | ¥8.3B | ¥9.2B | ¥7.8B | ¥11.1B |
| Deferred Tax | — | ¥-828M | ¥3.1B | ¥-178M | ¥-308M |
| Net Income (owners) | ¥14.5B | ¥14.1B | ¥17.0B | ¥17.1B | ¥23.4B |
| Comprehensive Income | — | ¥13.5B | ¥20.5B | ¥18.6B | ¥24.8B |
| EBITDA | ¥23.5B | ¥24.9B | ¥23.4B | ¥24.9B | ¥34.5B |
| Goodwill Amort. (J-GAAP) | — | ¥124M | ¥149M | ¥116M | ¥68M |
| EPS | ¥89.25 | ¥84.88 | ¥202.45 | ¥203.28 | ¥276.51 |
| Shares Outstanding | — | 163.1M | 83.9M | 84.1M | 84.4M |
| Shares Issued (total) | — | 171.0M | 88.2M | 88.2M | 88.7M |
| Treasury Shares | — | 7.9M | 4.3M | 4.1M | 4.3M |